Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB06414_DB08920_nanopub.RAr5mO0L6H2ivM9JBfOAjG258rVHU_yQ0sml1M_Y0rIqE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB06414_DB08920 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB06414_DB08920 label "DDI between Etravirine and Zuclopenthixol decanoate - Zuclopenthixol (especially oral dosage form) may experience a decrease in serum concentration when used concomitantly with etravirine. It is recommended to monitor zuclopenthixol therapy for efficacy. [drugbank_resource:DB06414_DB08920]" assertion.
- drugbank_resource:DB06414_DB08920 identifier "drugbank_resource:DB06414_DB08920" assertion.
- drugbank_resource:DB06414_DB08920 title "DDI between Etravirine and Zuclopenthixol decanoate - Zuclopenthixol (especially oral dosage form) may experience a decrease in serum concentration when used concomitantly with etravirine. It is recommended to monitor zuclopenthixol therapy for efficacy." assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06414_DB08920 assertion.
- drugbank:DB08920 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06414_DB08920 assertion.